Pharmacokinetics of melarsoprol in uninfected vervet monkeys.
about
Chemotherapy of second stage human African trypanosomiasis: comparison between the parenteral diamidine DB829 and its oral prodrug DB868 in vervet monkeysEfficacy of the novel diamidine compound 2,5-Bis(4-amidinophenyl)- furan-bis-O-Methlylamidoxime (Pafuramidine, DB289) against Trypanosoma brucei rhodesiense infection in vervet monkeys after oral administration.Pharmacokinetics and pharmacodynamics utilizing unbound target tissue exposure as part of a disposition-based rationale for lead optimization of benzoxaboroles in the treatment of Stage 2 Human African Trypanosomiasis.Arsthinol nanosuspensions: pharmacokinetics and anti-leukaemic activity on NB4 promyelocytic leukaemia cells.Discrepancy in plasma melarsoprol concentrations between HPLC and bioassay methods in patients with T. gambiense sleeping sickness indicates that melarsoprol is metabolized
P2860
Pharmacokinetics of melarsoprol in uninfected vervet monkeys.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Pharmacokinetics of melarsoprol in uninfected vervet monkeys.
@en
type
label
Pharmacokinetics of melarsoprol in uninfected vervet monkeys.
@en
prefLabel
Pharmacokinetics of melarsoprol in uninfected vervet monkeys.
@en
P2093
P1433
P1476
Pharmacokinetics of melarsoprol in uninfected vervet monkeys.
@en
P2093
P356
10.1016/0001-706X(94)90120-1
P577
1994-10-01T00:00:00Z